Telehealth Postop Follow up RCT

January 2, 2019 updated by: Elisha Jackson, Jackson, Elisha

Preferred Method of Postoperative Follow Up After Pelvic Reconstructive Surgery. (Phone Call Versus Clinic Visit): A Non-Inferiority Randomized Clinical Trial

A randomized controlled trial that will evaluate whether telephone two-week postoperative follow up visits are an acceptable and safe alternative to traditional face-to-face-clinic two-week postoperative visits.

Study Overview

Status

Unknown

Detailed Description

This is a two group, parallel randomized non-inferiority clinical trial at one institution evaluating telephone postoperative visits as non-inferior in patient satisfaction, patient preference, and patient safety, when compared with clinic postoperative visits. This protocol was written in accordance with CONSORT (Consolidated Standards of Reporting Trials) guidelines 2011.

Study Type

Interventional

Enrollment (Anticipated)

142

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • Recruiting
        • University of Florida Health
        • Contact:
        • Sub-Investigator:
          • Renee Bassaly, DO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women >18 desiring surgical management of prolapse or incontinence
  • English speaking
  • Willing and able to provide written and informed consent without assistance from medical surrogate or interpreter
  • Immediate access to telephone services (landline, mobile phone, office phone)

Exclusion Criteria:

  • Women <18
  • Non-English speaking
  • Unwilling and unable to provide written and informed consent without assistance from surrogate or interpreter
  • Hearing impairment
  • No access to telephone services (landline, mobile phone, office phone)
  • Grade 3 complication- a complication requiring surgical, endoscopic, or radiological intervention. [3]
  • Patient who did not attend any postoperative follow up visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Telephone Group

The patient randomized into the telephone follow up group, will be contacted, at the pre-scheduled date and time, by the urogynecology clinic nurse. The nurse will utilize a scripted series of postoperative questions, which are consistent with questions asked during our standard postoperative clinic visits.

Vital signs and physical examination will be deferred for the patients in the telephone follow up group.

Any patient responses that are not consistent with a usual postoperative course will be escalated to an in person visit. However, these patients will remain in the group, to which they were originally randomized, for research analysis purposes.

The patient randomized into the telephone follow up group, will be contacted, at the pre-scheduled date and time, by the urogynecology clinic nurse. The nurse will utilize a scripted series of postoperative questions, which are consistent with questions asked during our standard postoperative clinic visits.

Vital signs and physical examination will be deferred for the patients in the telephone follow up group.

Any patient responses that are not consistent with a usual postoperative course will be escalated to an in person visit. However, these patients will remain in the group, to which they were originally randomized, for research analysis purposes. (Intent to treat)

NO_INTERVENTION: In Person Clinic Visit Group
For the patient randomized into the clinic group, the clinic visit will entail questions about common postoperative complications (including fever, nausea/vomiting, pain, urinary symptoms, constipation, etc.). As per usual, vital signs and a focused physical examination will be completed at the clinic visit. All clinic visits will be performed by an FPRMS fellow and/or attending physician

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Satisfaction (questionnaire)
Time Frame: Survey will be provided at the six-week follow up visit.
Comparison of patient satisfaction as determined by completion of a non-validated, treatment non-specific satisfaction questionnaire between the two groups.
Survey will be provided at the six-week follow up visit.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient safety (adverse events)
Time Frame: Postoperative period up to 6 weeks
• Comparison of adverse events and Emergency Department (ED) visits between the two groups. Will be determined by reviewing the patient's record to identify adverse events as defined below
Postoperative period up to 6 weeks
Time Spent (post op telephone follow up compared to clinic follow up [minutes])
Time Frame: Calculated from time spent at the two week follow up visit
• Actual time spent on phone call during postoperative telephone follow up compared to time spent in clinic follow up measured in minutes.
Calculated from time spent at the two week follow up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Elisha J Jackson, MD, University of South Florida Morsani School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 9, 2018

Primary Completion (ANTICIPATED)

July 1, 2019

Study Completion (ANTICIPATED)

July 31, 2019

Study Registration Dates

First Submitted

December 30, 2018

First Submitted That Met QC Criteria

January 2, 2019

First Posted (ACTUAL)

January 3, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 3, 2019

Last Update Submitted That Met QC Criteria

January 2, 2019

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Telehealth Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Satisfaction

Clinical Trials on Telehealth 2 week postoperative visit

3
Subscribe